review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1177/145749690309200110 |
P698 | PubMed publication ID | 12705553 |
P50 | author | David Sebag-Montefiore | Q43195788 |
P2093 | author name string | P Hatfield | |
P2860 | cites work | Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer | Q59335217 |
Effective surgical adjuvant therapy for high-risk rectal carcinoma | Q33387384 | ||
Postoperative radiation therapy for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The Netherlands | Q33521466 | ||
Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial | Q33593850 | ||
No downstaging after short-term preoperative radiotherapy in rectal cancer patients | Q34205254 | ||
Chemoradiation schedules--what radiotherapy? | Q34501938 | ||
Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery | Q34522049 | ||
Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. | Q34540951 | ||
Low-dose preoperative radiation postpones recurrences in operable rectal cancer. Results of a randomized multicenter trial in western Norway | Q37997652 | ||
Preoperative infusional chemoradiation therapy for Stage T3 rectal cancer | Q39374122 | ||
Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project | Q39545521 | ||
Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience | Q39556490 | ||
Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. | Q40845805 | ||
The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function | Q43327482 | ||
Preoperative radiotherapy for colorectal cancer | Q43527642 | ||
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study | Q44012097 | ||
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. | Q44045712 | ||
Preoperative radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group Trial II. | Q45337054 | ||
Evaluation of the role of pre-operative magnetic resonance imaging in the management of rectal cancer. | Q52860184 | ||
Role of circumferential margin involvement in the local recurrence of rectal cancer. | Q52871348 | ||
Macroscopic Evaluation of Rectal Cancer Resection Specimen: Clinical Significance of the Pathologist in Quality Control | Q56441655 | ||
Rectal Cancer: What Can we Learn From the Dutch TME Study? How Will This Study Impact on Current Practice in the U.K.? | Q56530363 | ||
P433 | issue | 1 | |
P304 | page(s) | 65-73 | |
P577 | publication date | 2003-01-01 | |
P1433 | published in | Scandinavian Journal of Surgery | Q15720850 |
P1476 | title | The use of radiotherapy in rectal cancer | |
P478 | volume | 92 |
Q36325514 | An evaluation of four CT-MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patients |
Q30883626 | Training and quality assurance for rectal cancer: 20 years of data is enough |
Q43105772 | Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study |
Search more.